AMP-activated protein kinase alpha-2 beta-2 gamma-1 (AMPK α2β2γ1)

AMP-activated protein kinase (AMPK) α2β2γ1 is a heterotrimeric enzyme complex that serves as a master regulator of cellular energy homeostasis, particularly within skeletal muscle and cardiac tissues (Hardie et al., 2012; Wojtaszewski et al., 2005). It consists of a catalytic α2 subunit, a scaffolding β2 subunit, and a regulatory γ1 subunit, which together sense fluctuations in the cellular AMP:ATP ratio (Hardie, 2014). When energy levels are low, the complex is activated allosterically by AMP and through phosphorylation by upstream kinases like LKB1, leading to the activation of catabolic pathways such as glucose uptake and fatty acid oxidation (Viollet et al., 2009). Conversely, it suppresses energy-consuming anabolic processes like protein and lipid synthesis to preserve ATP (Hardie, 2011). Because of its role in enhancing insulin sensitivity and metabolic flux, AMPK α2β2γ1 is a major therapeutic target for treating type 2 diabetes and metabolic syndrome (Zhang et al., 2009). Pharmacological activators, including direct small-molecule agonists and indirect agents like metformin, are being developed to harness these metabolic benefits, though care must be taken to avoid potential cardiac side effects associated with systemic AMPK modulation (Myers et al., 2017).

Other names

PRKAA2/PRKAB2/PRKAG1 complexAMPK alpha-2/beta-2/gamma-15'-AMP-activated protein kinase subunit alpha-2, beta-2, and gamma-1AMPK alpha2beta2gamma1

Allosteric activation by AMP and ADP binding to the gamma subunit, and phosphorylation of the alpha subunit at Thr172 by upstream kinases such as LKB1 or CaMKK2, which stimulates ATP-producing catabolic pathways and inhibits ATP-consuming anabolic pathways (Hardie et al., 2012).